Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q62841612 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000126.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q62841612 | ||
| 024 | ‡a 0000-0002-2749-5301 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q62841612 | ||
| 100 | 0 | ‡a Ryan M Kramer ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Ryan M Kramer ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach. | ||
| 909 | ‡a (orcid) 0000000227495301 ‡9 1 | ||
| 919 | ‡a developmentofathermostablenanoemulsionadjuvantedvaccineagainsttuberculosisusingadesignofexperimentsapproach ‡A Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach. ‡9 1 | ||
| 996 | ‡2 NTA|072752521 | ||
| 996 | ‡2 NTA|420578102 | ||
| 996 | ‡2 LC|no2010186027 | ||
| 996 | ‡2 DNB|1028099088 | ||
| 996 | ‡2 NTA|104835516 | ||
| 996 | ‡2 NTA|304077208 | ||
| 996 | ‡2 NTA|43494873X | ||
| 996 | ‡2 LC|n 2019074351 | ||
| 996 | ‡2 NTA|241586372 | ||
| 996 | ‡2 LC|n 83143896 | ||
| 996 | ‡2 NTA|363513817 | ||
| 996 | ‡2 NTA|287797082 | ||
| 996 | ‡2 NTA|256326266 | ||
| 996 | ‡2 NTA|072732725 | ||
| 996 | ‡2 ISNI|000000038899411X | ||
| 996 | ‡2 ISNI|0000000389435897 | ||
| 996 | ‡2 J9U|987007275637305171 | ||
| 996 | ‡2 LC|n 89661106 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
